Long-term outcomes of thoracic transplant recipients following conversion to everolimus with reduced calcineurin inhibitor in a multicenter, open-label, randomized trial

Three-year results of an investigator-driven multicenter, international, randomized open-label de novo trial to prevent BOS after lung transplantation

(2015) Allan R. Glanville et al.   JOURNAL OF HEART AND LUNG TRANSPLANTATION

Improved long-term survival in Dutch heart transplant patients despite increasing donor age: the Rotterdam experience

(2015) Laurien E. Zijlstra et al.   TRANSPLANT INTERNATIONAL

Long-term evolution, secular trends, and risk factors of renal dysfunction following cardiac transplantation

(2014) Kim Lachance et al.   TRANSPLANT INTERNATIONAL

Renal Recovery After Conversion to an Everolimus-Based Immunosuppression in Early and Late Heart Transplant Recipients: A 12-Month Analysis

(2013) Sebastian Michel et al.   Experimental and Clinical Transplantation

Ten-Year Results of a Randomized Trial Comparing Tacrolimus Versus Cyclosporine A in Combination With Mycophenolate Mofetil After Heart Transplantation

(2013) Sonja Guethoff et al.   TRANSPLANTATION

Cyclosporine lowering with everolimus versus mycophenolate mofetil in heart transplant recipients: Long-term follow-up of the SHIRAKISS randomized, prospective study

(2012) Luciano Potena et al.   JOURNAL OF HEART AND LUNG TRANSPLANTATION

Solid Organ Allograft Survival Improvement in the United States: The Long-Term Does Not Mirror the Dramatic Short-Term Success

(2011) S. A. Lodhi et al.   AMERICAN JOURNAL OF TRANSPLANTATION

mTOR inhibitor–associated proteinuria in kidney transplant recipients

(2011) Fritz Diekmann et al.   Transplantation Reviews

Tacrolimus versus cyclosporine as primary immunosuppression after heart transplantation: systematic review with meta-analyses and trial sequential analyses of randomised trials

(2010) Luit Penninga et al.   EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY

Predictors of Renal Dysfunction at 1 Year in Heart Transplant Patients

(2010) Josep Navarro-Manchón et al.   TRANSPLANTATION

Cyclosporine Lowering With Everolimus or Mycophenolate to Preserve Renal Function in Heart Recipients: A Randomized Study

(2010) Luciano Potena et al.   TRANSPLANTATION

Two-Year Outcomes in Thoracic Transplant Recipients After Conversion to Everolimus With Reduced Calcineurin Inhibitor Within a Multicenter, Open-Label, Randomized Trial

(2010) Lars Gullestad et al.   TRANSPLANTATION

Everolimus With Reduced Calcineurin Inhibitor in Thoracic Transplant Recipients With Renal Dysfunction: A Multicenter, Randomized Trial

(2010) Lars Gullestad et al.   TRANSPLANTATION

Chronic Kidney Disease After Lung Transplantation: Incidence, Risk Factors, and Treatment

(2010) M. Paradela de la Morena et al.   TRANSPLANTATION PROCEEDINGS

Everolimus With Reduced Cyclosporine Versus MMF With Standard Cyclosporine in De Novo Heart Transplant Recipients

(2009) Hans B. Lehmkuhl et al.   TRANSPLANTATION